<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01270555</url>
  </required_header>
  <id_info>
    <org_study_id>1999-P-009198</org_study_id>
    <nct_id>NCT01270555</nct_id>
    <nct_alias>NCT01012024</nct_alias>
  </id_info>
  <brief_title>Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults</brief_title>
  <official_title>Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current Substance Use Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to conduct an open study to evaluate the efficacy and tolerability
      of Bupropion SR using clinically relevant doses in ADHD adults with a recent history of or
      current substance use disorders. We hypothesize that Bupropion SR will be effective in
      treating ADHD in this population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 1999</start_date>
  <primary_completion_date type="Actual">July 2001</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) Score</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Assesses 18 individual criteria symptoms using a severity grid (0 = not present, 3 = severe; overall minimum score = 0, maximum score = 54)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-reported Weekly Substance Use</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Number of subjects who self-report using at least one of illegal drugs or alcohol, at least once in a week.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impressions (CGI) Scale of Substance Use Disorder (SUD) Severity</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>CGI-S 1=not ill, 7=extremely ill</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impressions (CGI) Scale of ADHD Severity</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Global Severity (CGI-S) 1=not ill, 7=extremely ill</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Anxiety Scale (HAM-A)</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>minimum score (least severe anxiety) = 0, maximum (most severe) = 56</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Scale (HAM-D)</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>minimum score (least severe depression) = 0, maximum score (most severe) = 84</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>minimum score (least severe depression) = 0, maximum score (most severe) = 63</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder (ADHD)</condition>
  <condition>Substance Use Disorder (SUD)</condition>
  <arm_group>
    <arm_group_label>Bupropion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupropion SR</intervention_name>
    <description>100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum</description>
    <arm_group_label>Bupropion</arm_group_label>
    <other_name>Wellbutrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female outpatients 18 years old or older, up to 60 years old.

          -  Patients with the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), by
             DSM-IV, as manifested in clinical evaluation and confirmed by structured interview.

          -  Patients within the past 6 months known to abuse or to be dependent on alcohol or any
             drug (nicotine addiction not included)

        Exclusion Criteria:

          -  Any clinically unstable medical condition

          -  Clinically significant abnormal baseline laboratory values

          -  Mental retardation (I.Q. &lt;75) or Organic brain disorders

          -  Seizure disorder

          -  Patients with a history or an eating disorder including anorexia or bulimia nervosa

          -  Pregnant or nursing females

          -  Patients with current bipolar disorder

          -  Psychotic disorder of any type

          -  Patients on psychotropics known to treat ADHD (i.e. stimulants, tricyclics)

          -  Patients receiving psychotherapy known to treat ADHD (i.e. cognitive or
             cognitive/behavioral psychotherapy)

          -  Patients demonstrating active withdrawal from substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2011</study_first_posted>
  <results_first_submitted>January 7, 2011</results_first_submitted>
  <results_first_submitted_qc>January 31, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 25, 2011</results_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Timothy Wilens, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bupropion</title>
          <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bupropion</title>
          <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>DSM-IV Attention Deficit Hyperactivity Rating Scale (ADHD RS)</title>
          <description>Assesses 18 individual criteria symptoms on a severity grid (0=not present, 3=severe; overall minimum score = 0, maximum score = 54)</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.1" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Self-reported Weekly substance use</title>
          <description>Participants who self-report using at least one of illegal drugs or alcohol, at least once per week.</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical Global Impressions (CGI) Score for SUD Severity</title>
          <description>Global Severity 1=not ill, 7=extremely ill</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.0" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical Global Impressions (CGI) Score for ADHD Severity</title>
          <description>Global Severity 1=not ill, 7=extremely ill</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.0" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hamilton Anxiety Rating Scale (HAM-A)</title>
          <description>minimum (least severe anxiety) = 0, maximum (most severe) = 56</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.1" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hamilton Depression rating Scale (HAM-D)</title>
          <description>minimum (least severe depression) = 0, maximum (most severe) = 84</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.8" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beck Depression Inventory (BDI)</title>
          <description>minimum (least severe depression) = 0, maximum (most severe) = 63</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.9" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) Score</title>
        <description>Assesses 18 individual criteria symptoms using a severity grid (0 = not present, 3 = severe; overall minimum score = 0, maximum score = 54)</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) Score</title>
          <description>Assesses 18 individual criteria symptoms using a severity grid (0 = not present, 3 = severe; overall minimum score = 0, maximum score = 54)</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.4" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Global Impressions (CGI) Scale of Substance Use Disorder (SUD) Severity</title>
        <description>CGI-S 1=not ill, 7=extremely ill</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Global Impressions (CGI) Scale of Substance Use Disorder (SUD) Severity</title>
          <description>CGI-S 1=not ill, 7=extremely ill</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Global Impressions (CGI) Scale of ADHD Severity</title>
        <description>Global Severity (CGI-S) 1=not ill, 7=extremely ill</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Global Impressions (CGI) Scale of ADHD Severity</title>
          <description>Global Severity (CGI-S) 1=not ill, 7=extremely ill</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Self-reported Weekly Substance Use</title>
        <description>Number of subjects who self-report using at least one of illegal drugs or alcohol, at least once in a week.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Self-reported Weekly Substance Use</title>
          <description>Number of subjects who self-report using at least one of illegal drugs or alcohol, at least once in a week.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hamilton Anxiety Scale (HAM-A)</title>
        <description>minimum score (least severe anxiety) = 0, maximum (most severe) = 56</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Hamilton Anxiety Scale (HAM-A)</title>
          <description>minimum score (least severe anxiety) = 0, maximum (most severe) = 56</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hamilton Depression Scale (HAM-D)</title>
        <description>minimum score (least severe depression) = 0, maximum score (most severe) = 84</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Hamilton Depression Scale (HAM-D)</title>
          <description>minimum score (least severe depression) = 0, maximum score (most severe) = 84</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Beck Depression Inventory (BDI)</title>
        <description>minimum score (least severe depression) = 0, maximum score (most severe) = 63</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bupropion</title>
            <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
          </group>
        </group_list>
        <measure>
          <title>Beck Depression Inventory (BDI)</title>
          <description>minimum score (least severe depression) = 0, maximum score (most severe) = 63</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bupropion</title>
          <description>Once daily treatment with Bupropion with intention to treat ADHD and SUD.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Timothy Wilens, MD</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617-503-1053</phone>
      <email>twilens@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

